HNHacker News
TopNewBestAskShowJobs

chrisamiller

730 karma · joined February 21, 2012

Science!
submissionscomments
chrisamiller··on Yahoo Pipes End-Of-life Announcement
Thanks. Guess I should have specified "preferably free" too :)
chrisamiller··on Yahoo Pipes End-Of-life Announcement
Oh man, I use 3 or 4 pipes to filter various RSS feeds. Ugh. Good suggestions for replacements (especially those that don't require my own server) would be much appreciated.
chrisamiller··on 8^8 – Find another you
Well, not quite 50/50... :) https://en.wikipedia.org/wiki/Klinefelter_syndrome
chrisamiller··on [dead]
Yeah, rates are important, but also small sample size (and who's at fault matters - the companies claim that human drivers caused all 4).

So you're not wrong, but my point is that humans are awful drivers, prone to distraction and fatal crashes. (32,719 in 2013 alone). If anything else (terrorists, sharks, aliens) were causing 30k deaths a year, we'd wouldn't be blithely accepting it as the status quo and acting fearful of measures that could dramatically ameliorate the problem.

chrisamiller··on [dead]
In the last 8 months: - Number of human-driving auto accidents in US: ~10.6 mil - Number of self-driving auto accidents in US: 4 Guess which one merited an article? --- Editing to add that all 4 crashes were apparently caused by human drivers https://twitter.com/msquinn/status/597738756511277056
chrisamiller··on Tesla Energy
Yeah, that's the primary use, but there has been speculation here and elsewhere that a battery could be worthwhile just for exploiting the difference between peak and off-peak rates. This indicates that, at least for my area and usage, the answer is no, it's not worth it.
chrisamiller··on Tesla Energy
A quick analysis of our local (St Louis) rates for an average (1700 sq ft) suburban house indicate that time shifting to get peak rate savings isn't worth it:

Payback time on the 10kWh battery would be around 26 years, and on the 7kWh battery would be 33 years.

So, at least in the midwest, I think you'd have to be either using a ton of peak energy or coupling the battery pack with solar to make the investment worth it.

chrisamiller··on FriendFeed is shutting down
I'm with you there. I had a lot more free time in grad school than I do now (both personally and professionally). Judging from the updates I see on twitter and blogs, most of that core group has gone on to bigger, better, more time-consuming things.

I wonder if the kids these days are using snapchat to complain about how we're all dinosaurs. :)

chrisamiller··on FriendFeed is shutting down
I miss that interface and community. Even if FriendFeed was still around, though, I wonder if it would be as popular. That group contained the early adopters of internet communication among scientists, a movement that has now grown exponentially. My guess is that the signal would be overwhelmed by noise, or broken down into sub-groups by specialty, which would overwhelm the delightful serendipity of it all.
chrisamiller··on New paper claims that evolution has stopped in a bacterial species. Is it true?
> I'd be willing to bet that there is a healthy species of bacteria that has stopped evolving, that perfectly copies its dna when it divides, and never transfers dna horizontally

There are several flaws in your argument: 1) There is no known polymerase that has a fidelity of 100%. There will always be some number of replication errors when DNA is synthesized. 2) There are lots of mutagens in the environment. UV light, mutagenic chemicals, hell, even radioactive decay of mostly-stable elements will occasionally hit a base and cause a mutation.

So, no, there is certainly no species that meets your criteria for non-evolving.

chrisamiller··on Don't become a scientist (1999)
Sigh. This gets posted every few months and the title is still wrong. It's a great time to be a scientist, especially if you're into, say, computational biology. It's an awful time to shoot for a tenure track faculty position. There are lots of ways to do science, both in and out of academia, without the 'professor' title.
chrisamiller··on “You’re not allowed bioinformatics anymore”
Do you have evidence? If so, I'd like to see those data.
chrisamiller··on “You’re not allowed bioinformatics anymore”
The field is slowly coming around. I've been very harsh when peer-reviewing papers without proper code release and documentation. I know that I'm not alone. Both investigators and funding agencies are starting to understand the message. This is especially true as older folks retire and a new computationally-savvy group of folks ascends into senior positions on editorial boards, faculty review panels, and grant review panels.

Things may look messy in science, and they often are, but I'm optimistic about the future.

chrisamiller··on Finding the perfect house using open data
I was worried about commute times from three different points when looking for a house, so I wrote a quick and dirty little ruby script to hit the Google Driving Directions API. It tiles across the area you specify and spits out a kml file that can be loaded into google earth and lets you see which areas fit your parameters (https://github.com/chrisamiller/commute-times).

There's lots of room for improvement in the code, but it's in the same vein as what this guy did and helped us quite a bit.

chrisamiller··on State of MetaFilter
To be clear, not HN itself, but the community in general is very much about monetizing their work, getting venture capital, making a quick buck, yadda yadda.
chrisamiller··on State of MetaFilter
The vast majority of Metafilter pageviews are people who lurk and just read the content. (The $5 barrier to entry and reasonably small community is a feature, not a bug)

The vast majority of these lurkers originally hit the ask.metafilter site by searching for a specific question and landing on a thread where a MeFi member has asked the same thing. Those users were the ones being targeted by ads. So yes, it's pretty easy for a google algorithm change to reduce traffic by that much.

They aren't optimizing the site for search traffic or for growth. They're optimizing it for fantastic discussion and community. I realize that's a foreign concept here on HN, where growth and monetization are king, but I believe it's why Metafilter has remained a popular and influential site for over 15 years. (That's like 100 in internet-years...)

chrisamiller··on State of MetaFilter
When I'm on metafilter and I click on the 'lawschool' tag, it absolutely makes sense that the header says "Posts tagged with lawschool"

Their goal is not to optimize for Google, it's to optimize for users on the site. (This is one of the reasons that makes metafilter such a special community)

chrisamiller··on hr for your terminal
Simple and useful - thanks!
chrisamiller··on Stack Exchange tag correlations
FWIW, doesn't seem to allow me to look at the tag 'r'.

While I won't argue that R is an awful name for a programming language, it's a legitimate tag: https://stackoverflow.com/questions/tagged/r

chrisamiller··on Your body wasn’t built to last: a lesson from human mortality rates
There are some cancers driven by things like mismatch-repair defects, so that the amount of DNA damage grows very quickly over time, but these don't cause the majority of cancers. In liquid (blood) tumors, especially, these are very rare - The predominant mechanism is just the accumulation of random defects due to cellular division.

On the other end of the scale are things like automobile accidents, where incidence peaks in teenage years and decreases thereafter (with a possible second peak as vision and reflexes deteriorate in the elderly). My point is that neither of these fit the neat curve drawn by the author. When everything is lumped together, the curve fits, but trying to draw broad conclusions about mechanisms from that kind of aggregate data is foolish.

chrisamiller··on Your body wasn’t built to last: a lesson from human mortality rates
As a cancer biologist, I can tell you that at least some of these assumptions don't hold true. Acute Myeloid Leukemia is driven entirely by "accumulated lightning bolts". Every time your blood stem cells divide, a small number of replication errors occur randomly in the DNA. If one of these cells accumulate two to three of these mutations in the wrong genes, you will develop AML. The longer you live, the more likely it is that this will occur. Bottom line, everyone who lives long enough will eventually get cancer.

While I agree that these plots are interesting, it's dangerous to read too much into these without thinking more deeply about the vast number of ways that there are to die, many of which will have strikingly different age distributions.

(see http://www.sciencedirect.com/science/article/pii/S0092867412...)

chrisamiller··on Dr. Arjun Srinivasan: We’ve Reached “The End of Antibiotics, Period”
Even if you've never taken antibiotics, you're in the same boat as everyone else. The resistant bacteria are in the environment.

If your immune system works fine, there's less to worry about. The most urgent danger is to the very young, old, or immunocompromised because of illness or therapy. (That said, MRSA infections do happen in otherwise healthy people from time to time)

If you've been avoiding meat raised with antibiotics, you're part of the solution, because you're pushing the market away from the cheap short-term fix (antibiotics) towards more sustainable solutions without the societal consequences.

chrisamiller··on Solar panels help keep buildings cool, reducing A/C needs
Seems overly complex - just paint your roof white and reflect most of that light and heat back into the void of space.
chrisamiller··on A farewell to bioinformatics (2012)
Tell that to the tens of thousands of researchers who make use of the human reference genome daily. I don't even know what the guy is talking about there - imagining modern genetics or genomics without it is pretty much impossible.
chrisamiller··on A farewell to bioinformatics (2012)
As someone in the field, let me assure you: This article does not accurately reflect the state of the field.
chrisamiller··on A farewell to bioinformatics (2012)
Some thoughts on this article:

- This guy clearly has a limited understanding of the field. This quote is laughable: "There are only two computationally difficult problems in bioinformatics, sequence alignment and phylogenetic tree construction."

- As a bioinformatician, I feel sorry for this guy. Just like any other field, there are shitty places to work. If I was stuck in a lab where a demanding PI with no computer skills kept throwing the results of poorly designed experiments at me and asking for miracles, I'd be a little bitter too.

- Just like any other field, there are also lots of places that are great places to work and are churning out some pretty goddamn amazing code and science. I'm working in cancer genomics, and we've already done work where the results of our bioinformatic analyses have saved people's lives. Here's one high-profile example that got a lot of good press. (http://www.nytimes.com/2012/07/08/health/in-gene-sequencing-...)

- I'm in the field of bioinformatics to improve human health and understand deep biological questions. I care about reproducibility and accuracy in my code, but 90% of the time, I could give a rat's ass about performance. I'm trying to find the answer to a question, and if I can get that answer in a reasonable amount of time, then the code is good enough. This is especially true when you consider that 3/4 of the things I do are one-off analyses with code that will never be used again. (largely because 3/4 of experiments fail - science is messy and hard like that). If given a choice between dicking around for two weeks to make my code perfect, or cranking out something that works in 2 hours, I'll pretty much always choose the latter. ("Premature optimization is the root of all evil (or at least most of it) in programming." --Donald Knuth)

- That said, when we do come up with some useful and widely applicable code, we do our best to optimize it, put it into pipelines with robust testing, and open-source it, so that the community can use it. If his lab never did that, they're rapidly falling behind the rest of the field.

- As for his assertion that bad code and obscure file formats are job security through obscurity, I'm going to call bullshit. For many years, the field lacked people with real CS training, so you got a lot of biologists reading a perl book in their spare time and hacking together some ugly, but functional solutions. Sure, in some ways that was less than optimal, but hell, it got us the human genome. The field is beginning to mature, and you're starting to see better code and standard formats as more computationally-savvy people move in. No one will argue that things couldn't be improved, but attributing it to unethical behavior or malice is just ridiculous.

tl;dr: Bitter guy with some kind of bone to pick doesn't really understand or accurately depict the state of the field.

chrisamiller··on Impact of Major on Career Path for 15600 Williams College Alums
They're already overused in genome biology. They do a beautiful job of representing interchromosomal rearrangements in cancer, but don't actually convey a whole lot of information.
chrisamiller··on In Treatment for Leukemia, Glimpses of the Future
And there's always the chance that a drug to cure that particular mutation doesn't exist. What then? Spend millions on years of research to make the drug?

This is indeed the case for most mutations that we're finding in cancer genomes. (That's the bad news).

The good news is that many cancers do have "druggable" genes that are altered, and even though the cells have many mutations, attacking just the druggable gene is often enough to prolong life and improve outcomes.

The other good news is that even though many different genes can be mutated, there are a much smaller number of pathways that are altered. (those for cell cycle control, apoptosis, etc). By targeting key points in those pathways, one drug may be effective against dozens of different mutations.

chrisamiller··on In Treatment for Leukemia, Glimpses of the Future
To the best of my knowledge, this hasn't been published.
chrisamiller··on In Treatment for Leukemia, Glimpses of the Future
Most of 23andMe's customers don't really get sequencing. They get genotyped on a SNP chip, which only tells you about a million or so positions (out of ~3.2 billion).

The other product that 23andMe is starting to offer is exome sequencing, where they analyze just the coding regions of the genome (around 1% of the total content). This sort of analysis can be enormously useful and can provide much information, but will miss variations in non-coding regions. It also has limited ability to detect structural variations, where a chunk of DNA gets moved around, deleted, or duplicated.

What they did here was whole genome analysis, coupled with sequencing the RNA products of gene expression. This turned out to be enormously important, because the main driver of his cancer turned out to be over-expression of a gene.

← PreviousPage 4 of 5Next →